Immune response to 2-dose BNT162b2 vaccination and risk of SARS-CoV-2 breakthrough infection: The Shieldvacc-2 study
View ORCID ProfileLisa Seekircher, View ORCID ProfileZoltán Bánki, View ORCID ProfileJanine Kimpel, View ORCID ProfileAnnika Rössler, Helena Schäfer, Barbara Falkensammer, David Bante, Lukas Forer, Sebastian Schönherr, Teresa Harthaller, View ORCID ProfileMagdalena Sacher, View ORCID ProfileCornelia Ower, View ORCID ProfileLena Tschiderer, View ORCID ProfileHanno Ulmer, View ORCID ProfileFlorian Krammer, View ORCID ProfileDorothee von Laer, View ORCID ProfileWegene Borena, View ORCID ProfilePeter Willeit
doi: https://doi.org/10.1101/2022.04.19.22273872
